심혈관 건강보조제 시장 예측(-2034년) : 종류, 성분, 제형, 유통 채널, 지역별 세계 분석

According to Stratistics MRC, the Global Cardiovascular Health Supplements Market is accounted for $16.4 billion in 2026 and is expected to reach $38.1 billion by 2034 growing at a CAGR of 11.1% during the forecast period. Cardiovascular health supplements are dietary products designed to support and enhance the well-being of the cardiovascular system, which includes the heart and blood vessels. Key ingredients commonly found in cardiovascular health supplements include omega-3 fatty acids, coenzyme Q10, magnesium, potassium, and various B vitamins, all of which contribute to improved heart function. These supplements aim to address risk factors for cardiovascular diseases, such as high blood pressure, high cholesterol levels, and oxidative stress, by providing additional nutrients that support heart function.

According to the centers for disease control and prevention (CDC), in 2021, over 695,000 people in the U.S. died from heart disease, recorded as 1 out of every 5 deaths.

Market Dynamics:

Driver:

Government initiatives

Governments worldwide are promoting public health campaigns and policies that emphasize the importance of cardiovascular well-being. They collaborate with healthcare organizations to raise awareness about the risks of cardiovascular diseases and the role of a healthy lifestyle, including proper nutrition. Moreover, regulatory bodies establish standards for the quality, safety, and efficacy of cardiovascular health supplements, instilling consumer confidence in preventing or managing cardiovascular conditions, which boosts this market growth.

Restraint:

High costs

The development and production of high-quality cardiovascular health supplements involve extensive research, testing, and manufacturing processes, which contribute to the elevated costs associated with these products. This situation disproportionately affects individuals with lower incomes, creating an inequity in access to potentially beneficial cardiovascular health support. Additionally, the marketing and distribution expenses incurred by pharmaceutical companies further drive up prices, which are impeding this market expansion.

Opportunity:

Growing health awareness

Consumers become increasingly conscious of the impact of lifestyle choices on their well-being, including nutritional supplements that support cardiovascular health. Educational campaigns, both online and offline, play a crucial role in disseminating information about the importance of maintaining a healthy heart. However, individuals are proactively seeking ways to address cardiovascular risk factors, such as high cholesterol and blood pressure, through dietary interventions through various social media and online resources, which are driving this market.

Threat:

Side effects

The quality and purity of cardiovascular health supplements can vary significantly. Certain herbs commonly used in cardiovascular health supplements, such as ginkgo biloba or garlic, can have blood-thinning effects, which may increase the risk of bleeding in individuals taking blood thinners or undergoing surgery. Similarly, high doses of certain vitamins and minerals, such as vitamin E or magnesium, can have adverse effects when taken in excess, which is hampering this market size.

Covid-19 Impact

The COVID-19 pandemic has had negative impacts on the cardiovascular health supplement market globally, including in North America and Europe. Lockdowns, disruptions in the supply chain, and economic uncertainties have affected consumer spending patterns and purchasing behaviors. Additionally, supply chain disruptions have also affected the availability and distribution of cardiovascular health supplements, leading to fluctuations in product availability and pricing, which could potentially hinder market growth.

The synthetic supplements segment is expected to be the largest during the forecast period

The synthetic supplements segment is estimated to hold the largest share due to the fact that these are designed to mimic the benefits of naturally occurring compounds and are often standardized for consistency in dosage and effectiveness. Common synthetic ingredients in cardiovascular supplements include synthetic coenzyme Q10, folic acid, and certain forms of vitamin B. Moreover, manufacturers may use synthetic ingredients to ensure precise formulations and cost-effective production with specific dietary restrictions or preferences, which are driving this segment's growth.

The omega fatty acids segment is expected to have the highest CAGR during the forecast period

The omega fatty acids segment is anticipated to have highest CAGR during the forecast period due to the incorporation of essential fatty acids, particularly omega-3 and omega-6, to promote heart health. These fatty acids play a crucial role in reducing triglyceride levels, lowering blood pressure, and mitigating inflammation within blood vessels, all of which contribute to a healthier cardiovascular system. Additionally, consumers often turn to omega fatty acid supplements as a convenient way to ensure an adequate intake of these essential nutrients, which are boosting this segment's expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to the large and health-conscious population of the region, which exhibits a significant demand for cardiovascular supplements. This region is home to some of the major key players, such as Pharmavite LLC, Nature's Bounty Co., Amway Corporation, and Abbott Laboratories, that contribute to consumer confidence in the safety and efficacy of cardiovascular health supplements. In addition, the market reflects a trend toward clean labels, natural ingredients, and sustainable sourcing, thereby driving this region's expansion.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a growing aging population and a proactive approach to preventive healthcare. Governments and healthcare organizations in Europe actively promote public health initiatives, contributing to the rising adoption of preventive measures against cardiovascular diseases. Further, the regulatory landscape, characterized by stringent quality standards and labeling requirements, ensures product safety and transparency for consumers, which are propelling this region's growth.

Key players in the market

Some of the key players in the Cardiovascular Health Supplements Market include Natural Organics, Inc., NOW Health Group, Inc., Nordic Naturals, Bright Lifecare Pvt Ltd, DaVinci Laboratories of Vermont, Thorne HealthTech, Inc., Nestle, Amway, GNC Holdings, LLC, InVite Health, Sanofi S.A., USANA Health Sciences and Herbalife International of America, Inc.

Key Developments:

In October 2023, announced a collaboration to co-develop and co-commercialize asset TEV'574, currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn's Disease, two types of inflammatory bowel disease.

In September 2023, Nestle has announced an agreement with Advent International to acquire a majority stake in Grupo CRM, a premium chocolate player in Brazil.

In March 2023, Nestle and UNESCO have announced a new partnership to provide young people with the resources and the skills they need to develop and carry forward innovative solutions to achieve positive social impact in their communities.

Types Covered:

• Synthetic Supplements
• Natural Supplements

Ingredients Covered:

• Coenzyme Q10
• Vitamins & Minerals
• Omega Fatty Acids
• Herbs & Botanicals
• Other Ingredients

Forms Covered:

• Softgels
• Liquids
• Powders
• Tablets
• Capsules
• Other Forms

Distribution Channels Covered:

• Online
• Offline

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Cardiovascular Health Supplements Market, By Type

• 5.1 Introduction
• 5.2 Synthetic Supplements
• 5.3 Natural Supplements

6 Global Cardiovascular Health Supplements Market, By Ingredient

• 6.1 Introduction
• 6.2 Coenzyme Q10
• 6.3 Vitamins & Minerals
• 6.4 Omega Fatty Acids
• 6.5 Herbs & Botanicals
• 6.6 Other Ingredients

7 Global Cardiovascular Health Supplements Market, By Form

• 7.1 Introduction
• 7.2 Softgels
• 7.3 Liquids
• 7.4 Powders
• 7.5 Tablets
• 7.6 Capsules
• 7.7 Other Forms

8 Global Cardiovascular Health Supplements Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Online
• 8.3 Offline

9 Global Cardiovascular Health Supplements Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Natural Organics, Inc.
• 11.2 NOW Health Group, Inc.
• 11.3 Nordic Naturals
• 11.4 Bright Lifecare Pvt Ltd
• 11.5 DaVinci Laboratories of Vermont
• 11.6 Thorne HealthTech, Inc.
• 11.7 Nestle
• 11.8 Amway
• 11.9 GNC Holdings, LLC
• 11.10 InVite Health
• 11.11 Sanofi S.A.
• 11.12 USANA Health Sciences
• 11.13 Herbalife International of America, Inc